CLASS II Device recall · Reported 14 Mar 2018 · FDA Enforcement Report

Diastat anti-Nuclear antibody (Ana) / Diastat Ana Elisa recalled

Euro Diagnostica AB is recalling Diastat anti-Nuclear antibody (Ana) / Diastat Ana Elisa, distributed nationwide in the US. The recall was initiated on 15 Oct 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 07340058410486. Lot numbers: SS 1500 and SS 2009.
Quantity recalled1090

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0929-2018
FDA event ID
79183
Recalling firm
Euro Diagnostica AB, Malmo, N/A
Classification
Class II
Status
Terminated
Recall initiated
15 Oct 2015
FDA classified
8 Mar 2018
Reported
14 Mar 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

15 Oct 2015Recall initiated by company
8 Mar 2018Classified by FDA+875 days
14 Mar 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Complaint investigation concluded that although product quality requirements stated in the instructions for use were met at lot release, the high background in the ELISA plate, the strong IgM conjugate, and the low reference control led to an increased risk of equivocal and/or false positive sample test results for the two FANA200 kit lots SS 1500 and SS 2009.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

DIASTAT anti-Nuclear antibody (ANA) / DIASTAT ANA ELISA. Catalog Number: FANA200. Product Usage: The DIASTAT¿ anti-nuclear antibody (ANA) test is a qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of ANAs in human serum or EDTA plasma. It detects ANAs against Sm, Sm/RNP, Ro (SS-A), La (SS-B), Scl- 70, Jo-1, dsDNA, histone and centromere antigens.The test may be used to screen out samples which are negative for all ANAs. Samples that give a positive test result should be further tested to identify the antigen-specific antibody or antibodies present. Quantitative/qualitative ELISA kits are available for the individual detection of Sm, Sm/RNP, Ro (SS-A), La (SS-B), dsDNA and centromere ANAs. Qualitative kits are available for the individual detection of Scl-70 and Jo-1. ANA detection represents one parameter in a multicriterion diagnostic process.

Where it was distributed

Worldwide Distribution and US. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Complaint investigation concluded that although product quality requirements stated in the instructions for use were met at lot release, the high background in the ELISA plate, the strong IgM conjugate, and the low reference control led to an increased risk of equivocal and/or false positive sample test results for the two FANA200 kit lots SS 1500 and SS 2009.

Which lots are affected?

UDI: 07340058410486. Lot numbers: SS 1500 and SS 2009.

Where was it sold?

Worldwide Distribution and US. Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Euro Diagnostica AB

All 8

Other Test Kits & Diagnostics recalls

All 2,656